Gene Therapy for Hearing Loss—Will the Price Be Right?

This Viewpoint examines questions about drug pricing, patient access, and fiscal sustainability of novel gene therapies for autosomal recessive deafness 9.

Authors

Institutions

Publication Details

Journal
JAMA Otolaryngology–Head & Neck Surgery
Published
2025-03-06
DOI
https://doi.org/10.1001/jamaoto.2024.5189
Citations
4
Primary Topic
Williams Syndrome Research
Type
article
Field-Weighted Citation Impact
5.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gene Therapy for Hearing Loss—Will the Price Be Right?

Vinay K. Rathi, Lauren E. Miller, Oliver F. Adunka
4 citations
JAMA Otolaryngology–Head & Neck Surgery
Williams Syndrome Research
5.27
article

Gene Therapy for Hearing Loss—Will the Price Be Right?

Vinay K. Rathi, Lauren E. Miller, Oliver F. Adunka
article en
4 citations

Abstract

This Viewpoint examines questions about drug pricing, patient access, and fiscal sustainability of novel gene therapies for autosomal recessive deafness 9.

JAMA Otolaryngology–Head & Neck SurgeryVol. 151(4)
Office of Multidisciplinary Activities (US), The Ohio State University (US)
Openalex Percentile: Top 5%
Williams Syndrome Research
5.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gene Therapy for Hearing Loss—Will the Price Be Right? — Vinay K. Rathi, Lauren E. Miller, et al. · JAMA Otolaryngology–Head & Neck Surgery (2025) | TGRS Research Map | TGRS